US Stock MarketDetailed Quotes

CATX Perspective Therapeutics

Watchlist

2.7100
+0.0500+1.88%

Close Feb 26 16:00 ET

2.7100
0.00000.00%

Post 20:01 ET

183.16MMarket Cap-1.82P/E (TTM)

Perspective Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Perspective Therapeutics Q4 2024 Estimates Date

Currency：USDMar 26, 2025

	Estimate	YoY
Revenue	297.76K	+106.07%
EPS	-0.25	+72.60%

Analyst Rating

Strong Buy

Feb 26, 2025

Perspective Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 151.330K	--
Mar 26, 2025	2024/Q4	-- / 297.760K	--
Nov 12, 2024	2024/Q3	369.000K / 237.910K	--
Aug 12, 2024	2024/Q2	526.000K / 135.630K	--
May 15, 2024	2024/Q1	325.000K / 68.800K	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 151.330K--

Mar 26, 20252024/Q4-- / 297.760K--

Nov 12, 20242024/Q3369.000K / 237.910K--

Aug 12, 20242024/Q2526.000K / 135.630K--

May 15, 20242024/Q1325.000K / 68.800K--

Unlock Free Earnings Estimates

Open Account

Perspective Therapeutics Earnings Reports

Perspective Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 12, 2024 16:18 ET

Perspective Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 13, 2024 16:10 ET

Perspective Therapeutics | 10-Q: Q1 2024 Earnings Report

May 15, 2024 22:44 ET

Perspective Therapeutics | 10-K: FY2023 Annual Report

Mar 28, 2024 08:39 ET